Catalyst Pharmaceutical Partners, Inc. (CPRX) Reports First Quarter 2013 Financial Results
5/16/2013 9:01:44 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Reports Fourth Quarter and Year-End 2012 Financial Results
4/2/2013 11:59:50 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)
3/27/2013 10:51:03 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) to Present at 25th Annual ROTH Conference
3/7/2013 11:27:54 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
3/5/2013 11:23:25 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Launches New Website
2/21/2013 11:29:15 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Provides Update on Research and Development Pipeline
2/11/2013 12:18:48 PM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) to Present at 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/5/2013 12:17:15 PM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement
12/27/2012 8:56:27 AM
More...
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Automatic Conversion of $5 Million Promissory Note Into Shares of Common Stock
12/11/2012 10:00:38 AM
More...
|
|